Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) posted its earnings results on Monday. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

Abingdon Health Price Performance

Shares of Abingdon Health stock opened at GBX 6.45 ($0.08) on Wednesday. The firm has a market cap of £12.49 million, a P/E ratio of -15.68 and a beta of 0.13. The firm’s 50-day simple moving average is GBX 7.46 and its 200-day simple moving average is GBX 7.96. Abingdon Health has a twelve month low of GBX 6 ($0.08) and a twelve month high of GBX 11.75 ($0.15). The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.